Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma

David Liu, Elizabeth R. Plimack, Jean Hoffman-Censits, Levi A. Garraway, Joaquim Bellmunt, Eliezer Van Allen, Jonathan E. Rosenberg

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1094-1096
Number of pages3
JournalJAMA oncology
Volume2
Issue number8
DOIs
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

Xeroderma Pigmentosum Group D Protein
Neoplasm Invasiveness
Antineoplastic Combined Chemotherapy Protocols
Neoadjuvant Therapy
Transitional Cell Carcinoma
Urinary Bladder Neoplasms
Reproducibility of Results
Smooth Muscle
Urinary Bladder
Cohort Studies
Biomarkers
Carcinoma
Drug Therapy
Muscles

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma. / Liu, David; Plimack, Elizabeth R.; Hoffman-Censits, Jean; Garraway, Levi A.; Bellmunt, Joaquim; Allen, Eliezer Van; Rosenberg, Jonathan E.

In: JAMA oncology, Vol. 2, No. 8, 01.08.2016, p. 1094-1096.

Research output: Contribution to journalLetter

Liu, David ; Plimack, Elizabeth R. ; Hoffman-Censits, Jean ; Garraway, Levi A. ; Bellmunt, Joaquim ; Allen, Eliezer Van ; Rosenberg, Jonathan E. / Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma. In: JAMA oncology. 2016 ; Vol. 2, No. 8. pp. 1094-1096.
@article{9f3330e58a0c478b9a64c3ec44d611ca,
title = "Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma",
author = "David Liu and Plimack, {Elizabeth R.} and Jean Hoffman-Censits and Garraway, {Levi A.} and Joaquim Bellmunt and Allen, {Eliezer Van} and Rosenberg, {Jonathan E.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1001/jamaoncol.2016.1056",
language = "English (US)",
volume = "2",
pages = "1094--1096",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Clinical validation of chemotherapy response biomarker ERCC2 in muscle-invasive urothelial bladder carcinoma

AU - Liu, David

AU - Plimack, Elizabeth R.

AU - Hoffman-Censits, Jean

AU - Garraway, Levi A.

AU - Bellmunt, Joaquim

AU - Allen, Eliezer Van

AU - Rosenberg, Jonathan E.

PY - 2016/8/1

Y1 - 2016/8/1

UR - http://www.scopus.com/inward/record.url?scp=85016513285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016513285&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2016.1056

DO - 10.1001/jamaoncol.2016.1056

M3 - Letter

C2 - 27310333

AN - SCOPUS:85016513285

VL - 2

SP - 1094

EP - 1096

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 8

ER -